AstraZeneca’s IMFINZI® (durvalumab) plus chemotherapy has been approved by the US Food and Drug Administration (FDA) for the treatment of adult patients struggling with…

Brightside Health, the provider of a mental care delivery platform, has launched a new service focusing on helping those struggling with substance…